Laserfiche WebLink
Exhibit K <br />SubdiN,ision and Special District Settlement Participation Form <br />Governmental Entity: City of Batesville State: AR <br />Authorized Signatory: Mayor Rick Elumbaugh <br />Address 1: 500 E. Main Street <br />Address 2: <br />City, State, Zip: Batesville, AR 72501 <br />Phone: 870-698-2400 <br />Email: mayor@cityofbatesville.com <br />The governmental entity identified above ("Governmental Entity"), in order to obtain and in <br />consideration for the benefits provided to the Governmental Entity pursuant to the Agreement <br />dated November 22, 2022 ("Teva Settlement"), and acting through the undersigned authorized <br />official, hereby elects to participate in the Teva Settlement, release all Released Claims against all <br />Released Entities, and agrees as follows. <br />1. The Governmental Entity is aware of and has reviewed the Teva Settlement, understands that <br />all terms in this Election and Release have the meanings defined therein, and agrees that by <br />this Election, the Governmental Entity elects to participate in the Teva Settlement as provided <br />therein. <br />2. Following the execution of this Settlement Participation Form, the Governmental Entity shall <br />comply with Section III.B of the Teva Settlement regarding Cessation of Litigation Activities. <br />3. The Governmental Entity shall, within 14 days of the Reference Date and prior to the filing of <br />the Consent Judgment, file a request to dismiss with prejudice any Released Claims that it has <br />filed. With respect to any Released Claims pending in In re National Prescription Opiate <br />Litigation, MDL No. 2804, the Governmental Entity authorizes the Plaintiffs' Executive <br />Committee to execute and file on behalf of the Governmental Entity a Stipulation of Dismissal <br />With Prejudice substantially in the form found at https://nationalopioidsettlement.com. <br />4. The Governmental Entity agrees to the terms of the Teva Settlement pertaining to <br />Subdivisions as defined therein. <br />5. By agreeing to the terms of the Teva Settlement and becoming a Releasor, the Governmental <br />Entity is entitled to the benefits provided therein, including, if applicable, monetary payments <br />beginning after the Effective Date. <br />6. The Governmental Entity agrees to use any monies it receives through the Teva Settlement <br />solely for the purposes provided therein. <br />7. The Governmental Entity submits to the jurisdiction of the court in the Governmental Entity's <br />state where the Consent Judgment is filed for purposes limited to that court's role as provided <br />in, and for resolving disputes to the extent provided in, the Teva Settlement. <br />